SCHEMBL2379568

SCHEMBL2379568

CC(=O)OCCCCOCC(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 3/20 0.43
CHRM5 P08912 2/20 0.39
CHRM1 P11229 2/20 0.39
CHRM3 P20309 2/20 0.39
PGR P06401 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
HTR1A P08908 1/20 0.39
CHRNB2 P17787 1/20 0.39
TBXA2R P21731 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRNA10 Q9GZZ6 1/20 0.39
CHRNA9 Q9UGM1 1/20 0.39
LMNA P02545 2/20 0.39
APOBEC3A P31941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196240 0.96 ALDH1A1 (0.50) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL1476532 0.87 ALDH1A1 (0.58) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL3341579 0.86 ALDH1A1 (0.45) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL599181 0.85 TSHR (0.56) ALDH1A1TSHRCHRM5CHRM1CHRM3
Acetic Acid Butyl Ester SCHEMBL10940149 0.84 ALDH1A1 (0.69) ALDH1A1TSHRSMN1; SMN2LMNARAB9A
SCHEMBL6661477 0.82 ALDH1A1 (0.64) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL14870880 0.82 ALDH1A1 (0.48) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL17435831 0.79 TSHR (0.43) ALDH1A1TSHRCHRM5CHRM1CHRM3
SCHEMBL26724992 0.79 PAOX (0.40) ALDH1A1TSHRPLA2G2CSPHK2SPHK1
SCHEMBL11858528 0.79 SPHK1 (0.42) ALDH1A1PLA2G2CSPHK2SPHK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228739-A1 COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, AND CURED PRODUCT ADEKA CORPORATION (JP) 2024-07-11 US disclosed
US-11678562-B2 Methods and systems of organic semiconducting polymers PHILLIPS 66 COMPANY (US) 2023-06-13 US disclosed
US-11600779-B2 Methods and systems of organic semiconducting polymers PHILLIPS 66 COMPANY (US) 2023-03-07 US disclosed
WO-2022249879-A1 COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, AND CURED PRODUCT 株式会社ADEKA 2022-12-01 WO disclosed
US-11440092-B2 Method for manufacturing copper powder, resin composition, method for forming cured product, and cured product ADEKA CORPORATION (JP) 2022-09-13 US disclosed
CN-107922589-B Resin composition and cured product 株式会社ADEKA 2022-05-03 CN disclosed
US-11289653-B2 Methods and systems of organic semiconducting polymers PHILLIPS 66 COMPANY (US) 2022-03-29 US disclosed
CN-110248750-B Method for producing copper powder, resin composition, method for forming cured product, and cured product 株式会社ADEKA 2021-07-23 CN disclosed
CN-107614481-B Preparation of high-conductivity copper film 加拿大国家研究委员会 2021-05-07 CN disclosed
EP-3307705-B1 PREPARATION OF HIGH CONDUCTIVITY COPPER FILMS NAT RES COUNCIL CANADA (CA) 2021-05-05 EP disclosed
US-20140252278-A1 BIBENZO[B]FURAN COMPOUND, PHOTOELECTRIC CONVERSION MATERIAL, AND PHOTOELECTRIC CONVERSION ELEMENT ADEKA CORPORATION (JP) 2014-09-11 US disclosed
EP-2772494-A1 BIBENZO[B]FURAN COMPOUND, PHOTOELECTRIC CONVERSION MATERIAL, AND PHOTOELECTRIC CONVERSION ELEMENT Adeka Corporation (JP) 2014-09-03 EP disclosed
EP-2684917-A1 ZINC OXIDE FILM-FORMING COMPOSITION, ZINC OXIDE FILM PRODUCTION METHOD, AND ZINC COMPOUND Adeka Corporation (JP) 2014-01-15 EP disclosed
US-20130323413-A1 ZINC OXIDE FILM-FORMING COMPOSITION, ZINC OXIDE FILM PRODUCTION METHOD, AND ZINC COMPOUND ADEKA CORPORATION (JP) 2013-12-05 US disclosed
US-8278249-B2 Composition for forming thick oxide superconductor film and process for producing thick tape-shaped oxide superconductor film ADEKA CORPORATION (JP) 2012-10-02 US disclosed
US-20110237440-A1 COMPOSITION FOR FORMING THICK OXIDE SUPERCONDUCTOR FILM AND PROCESS FOR PRODUCING THICK TAPE-SHAPED OXIDE SUPERCONDUCTOR FILM ADEKA CORPORATION (JP) 2011-09-29 US disclosed
US-7819965-B2 Coating formulation and process for the production of titanate-based ceramic film with the coating formulation ADEKA CORPORATION (JP) 2010-10-26 US disclosed
US-20100159128-A1 Niobium 2-ethylhexanoate derivative, method of producing the derivative, organic acid metal salt composition containing the derivative, and method of producing thin film using the composition YOSHINAKA ATSUYA 2010-06-24 US disclosed
US-20090136658-A1 Niobium 2-Ethylhexanoate Derivative, Method Of Producing The Derivative, Organic Acid Metal Salt Composition Containing The Derivative, And Method Of Producing Thin Film Using The Composition ADEKA CORPORATION (JP) 2009-05-28 US disclosed
US-20080090006-A1 COATING FORMULATION AND PROCESS FOR THE PRODUCTION OF TITANATE-BASED CERAMIC FILM WITH THE COATING FORMULATION ADEKA CORPORATION (JP) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136658-A1 Niobium 2-Ethylhexanoate Derivative, Method Of Producing The Derivative, Organic Acid Metal Salt Composition Containing The Derivative, And Method Of Producing Thin Film Using The Composition HDHD5, HAO2, CA2 ALDH1A1 3104/4885TSHR 4082/4885CHRM5 1139/4885
US-20130323413-A1 ZINC OXIDE FILM-FORMING COMPOSITION, ZINC OXIDE FILM PRODUCTION METHOD, AND ZINC COMPOUND CXXC4, CXXC5, ZRANB2 ALDH1A1 2113/4885TSHR 3881/4885CHRM5 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.